Free Trial

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Buys 157,610 Shares of agilon health, inc. (NYSE:AGL)

agilon health logo with Medical background

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its stake in agilon health, inc. (NYSE:AGL - Free Report) by 24.6% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 797,658 shares of the company's stock after buying an additional 157,610 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC owned approximately 0.19% of agilon health worth $1,516,000 at the end of the most recent quarter.

Several other large investors have also modified their holdings of the company. Empowered Funds LLC acquired a new stake in shares of agilon health during the fourth quarter worth $97,000. Rhumbline Advisers lifted its stake in shares of agilon health by 6.2% in the 4th quarter. Rhumbline Advisers now owns 419,587 shares of the company's stock worth $797,000 after acquiring an additional 24,420 shares during the period. Alberta Investment Management Corp acquired a new stake in shares of agilon health in the 4th quarter valued at approximately $1,564,000. Ieq Capital LLC acquired a new stake in shares of agilon health in the 4th quarter worth approximately $26,000. Finally, Handelsbanken Fonder AB increased its holdings in agilon health by 47.9% during the 4th quarter. Handelsbanken Fonder AB now owns 75,000 shares of the company's stock valued at $142,000 after acquiring an additional 24,300 shares in the last quarter.

agilon health Trading Down 3.9%

Shares of agilon health stock traded down $0.09 on Thursday, reaching $2.20. 2,670,093 shares of the company were exchanged, compared to its average volume of 4,967,202. agilon health, inc. has a fifty-two week low of $1.50 and a fifty-two week high of $7.73. The firm has a market capitalization of $910.69 million, a price-to-earnings ratio of -2.34 and a beta of 0.14. The company has a current ratio of 1.29, a quick ratio of 1.29 and a debt-to-equity ratio of 0.06. The stock has a fifty day moving average price of $3.46 and a 200-day moving average price of $3.20.

agilon health (NYSE:AGL - Get Free Report) last issued its earnings results on Tuesday, May 6th. The company reported $0.03 EPS for the quarter, topping the consensus estimate of ($0.01) by $0.04. The business had revenue of $1.53 billion during the quarter, compared to analysts' expectations of $1.50 billion. agilon health had a negative return on equity of 47.84% and a negative net margin of 6.88%. agilon health's revenue was down 4.5% compared to the same quarter last year. During the same quarter last year, the firm posted ($0.02) earnings per share. On average, analysts expect that agilon health, inc. will post -0.59 EPS for the current year.

Analyst Upgrades and Downgrades

A number of equities analysts have recently weighed in on the company. Barclays boosted their price target on agilon health from $2.00 to $3.00 and gave the stock an "underweight" rating in a report on Thursday, May 8th. The Goldman Sachs Group raised their price target on shares of agilon health from $2.50 to $5.00 and gave the company a "neutral" rating in a report on Thursday, May 8th. Cowen reiterated a "hold" rating on shares of agilon health in a research note on Tuesday, April 15th. Wells Fargo & Company decreased their target price on agilon health from $6.00 to $5.00 and set an "overweight" rating for the company in a research report on Tuesday, May 13th. Finally, Stifel Nicolaus increased their price objective on shares of agilon health from $2.00 to $3.00 and gave the stock a "hold" rating in a research note on Wednesday, February 26th. Two investment analysts have rated the stock with a sell rating, eleven have given a hold rating and five have issued a buy rating to the company. According to MarketBeat, agilon health presently has a consensus rating of "Hold" and a consensus price target of $4.79.

View Our Latest Report on AGL

agilon health Company Profile

(Free Report)

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.

Further Reading

Institutional Ownership by Quarter for agilon health (NYSE:AGL)

Should You Invest $1,000 in Agilon Health Right Now?

Before you consider Agilon Health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Agilon Health wasn't on the list.

While Agilon Health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Cheap Growth Stocks Set to Explode This Summer
The Next NVIDIA? Quantum Computing Stocks Set for Explosive Growth
5 Stocks to BUY NOW in July 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines